4/A: Bausch Health CEO Thomas Appio Corrects RSU Vesting Schedule in Amended SEC Filing
SEC Filing
Thomas Appio, CEO of Bausch Health Companies Inc., files an amended SEC Form 4/A to correct the vesting schedule of restricted share units (RSUs) previously reported.
Summary
- Bausch Health Companies Inc. CEO Thomas Appio filed an amended SEC Form 4/A on June 5, 2024, to correct a previously reported RSU vesting schedule.
- The original Form 4, filed on March 4, 2024, contained an error regarding the vesting terms.
- The corrected filing clarifies that the 519,328 RSUs awarded on February 29, 2024, will vest in three equal installments on the first three anniversaries of the grant date, contingent upon continued service.
- Following the reported transaction, Appio beneficially owns 1,486,338 common shares.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing correcting an administrative error. It doesn't indicate any fundamental issues with the company, but the initial error could be seen as slightly negative.
Industry Context
This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies. It ensures transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The correction of the RSU vesting schedule ensures accurate information for shareholders regarding executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of the RSU award. |
| 03/04/2024 | Date of the original Form 4 filing with incorrect vesting information. |
| 06/05/2024 | Date of the amended Form 4/A filing to correct the RSU vesting schedule. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.